SEC Form 4/A · accession 0001140361-15-037049
MACROGENICS INC · MGNX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Jon Marc Wigginton
Officer — Sr VP, Clinical
Period of report
Oct 1, 2015
Accepted (ET)
Oct 7, 2015 · 4:08 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001125345
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Oct 1, 2015 | M | 5,000 | $4.70 | A | 5,000 | D | |
| Common StockF1 | Oct 1, 2015 | S | 5,000 | $21.11 | D | 0 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F2 | $4.70 | Oct 1, 2015 | M | 5,000 | D | — | Jul 18, 2023 | Common Stock | 5,000 | 45,194 | D |
Explanation of responses
- F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 17, 2015.
- F212.5% of the shares underlying the option became exercisable on January 19, 2014, and 6.25% of the shares underlying the option become exercisable on the first day of each three month anniversary thereafter.
Remarks
Amendment filed solely to correct adoption date of 10b5-1 trading plan in Footnote 1.